Inhibrx Biosciences Inc (INBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | INBX | AZN | AMGN | GILD | BMY |
| Company | Inhibrx Biosciences Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 118.41 | 195.21 | 345.52 | 134.02 | 58.84 |
| High | 131.00 | 196.64 | 350.69 | 134.68 | 59.25 |
| Low | 116.07 | 191.81 | 345.50 | 132.79 | 58.64 |
| Latest | 119.93 | 192.30 | 348.62 | 133.64 | 59.02 |
| Change | +4.84 | -2.51 | +2.70 | +0.74 | +0.22 |
| % Change | +4.21% | -1.29% | +0.78% | +0.56% | +0.37% |
| Volume | 955,400 | 2,179,200 | 2,031,400 | 3,870,400 | 6,510,100 |
| 20-Day Average Volume | 430,655 | 1,903,835 | 2,448,195 | 5,186,940 | 9,499,425 |
| Previous Close | 115.09 | 194.81 | 345.92 | 132.90 | 58.80 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 77.16 | 199.04 | 349.31 | 137.98 | 59.17 |
| 20-Day Raw Stochastic | 63.91% | 38.80% | 55.61% | 19.78% | 35.96% |
| 20-Day Relative Strength | 75.60 | 45.18 | 46.75 | 40.06 | 50.20 |
| Weighted Alpha | +382.58 | +34.89 | +23.13 | +25.64 | +26.99 |
| Today's Opinion | 72% Buy | 64% Buy | 24% Buy | 24% Buy | 48% Buy |
| Previous Opinion | 72% Buy | 72% Buy | 24% Buy | 24% Buy | 48% Buy |
| Last Month's Opinion | 8% Sell | 40% Buy | 56% Buy | 56% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +44.30% since 04/16/26 | -4.08% since 04/16/26 | -0.22% since 04/16/26 | -3.54% since 04/16/26 | +0.10% since 04/16/26 |
| Low | 80.83 on 04/20/26 | 191.81 on 04/23/26 | 340.06 on 04/21/26 | 131.34 on 04/22/26 | 57.79 on 04/21/26 |
| High | 155.29 on 04/22/26 | 205.30 on 04/17/26 | 356.90 on 04/20/26 | 139.76 on 04/17/26 | 60.48 on 04/17/26 |
| 1-Month | |||||
| %Chg | +85.56% since 03/23/26 | +4.47% since 03/23/26 | -0.33% since 03/23/26 | -2.69% since 03/23/26 | +3.54% since 03/23/26 |
| Low | 57.30 on 03/27/26 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 131.34 on 04/22/26 | 56.45 on 03/24/26 |
| High | 155.29 on 04/22/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | +60.63% since 01/23/26 | +3.44% since 01/23/26 | +1.12% since 01/23/26 | -1.68% since 01/23/26 | +8.00% since 01/23/26 |
| Low | 57.30 on 03/27/26 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 131.34 on 04/22/26 | 54.21 on 01/29/26 |
| High | 155.29 on 04/22/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +322.88% since 10/23/25 | +15.29% since 10/23/25 | +19.03% since 10/23/25 | +10.68% since 10/23/25 | +34.66% since 10/23/25 |
| Low | 46.01 on 10/24/25 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 155.29 on 04/22/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,681,120 | 302,132,384 | 186,687,840 | 164,958,400 | 120,054,016 |
| Shares Outstanding, K | 14,607 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 1,300,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -140,060,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -35,260,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 1.82 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.11 on 03/19/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/13/26 | 04/29/26 | 04/30/26 | 05/07/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.37 | 15.78 | 16.35 | 9.66 |